BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Coldstream Laboratories Inc. Awarded 5-Year Contract With the National Cancer Institute


9/25/2013 9:02:14 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LEXINGTON, KY--(Marketwired - September 24, 2013) -

Coldstream Laboratories, Inc., a provider of sterile drug product development and manufacturing services, has announced that they have been awarded a 5-year contract with the National Cancer Institute ("NCI") under solicitation number N02CM37007-11 (contract# HHSN261201300031I) entitled "Development and Production of Parenteral Dosage Forms for Clinical Studies."

The contract lasts for five years with the objective of developing and producing pharmaceutically acceptable parenteral dosage forms of cancer drugs for human use. Certain lead agents selected by the NCI will be assigned for development and production as parenteral products. The NCI has been a leader in field of cancer research since its establishment in 1937.

"The requirements for this program mesh perfectly with Coldstream's capabilities and facilities. We couldn't be more pleased to be awarded this opportunity to work with the NCI," said Eric W. Smart, Coldstream's President and Chief Executive Officer. "We work hard to ensure the highest degree of quality in everything we do and being awarded this contract indicates that we are succeeding. Being awarded this contract affords Coldstream the opportunity to continue to make an impact in the field of cancer research and help advance oncologic care for the millions of people impacted by cancer every year."

Coldstream Laboratories, Inc., based in Lexington, KY, is a privately held specialty pharmaceutical contract manufacturing organization. The company was formed in 2007 as a spin-off from the University of Kentucky's Center for Pharmaceutical Sciences and Technology. Coldstream operates Kentucky's only parenteral manufacturing facility.

For more information, visit www.coldstreamlabs.com or email customerservice@coldstreamlabs.com.


Contact:
Chris Verbicky
Tel: 518-882-8073
Email: Email Contact

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES